LLYNEUTRAL

Revenue Growth (YoY)

55.5%

Updated 25h ago

Sector Performance

98th percentile

LLY

55.5%

Sector Median

7.9%

Sector Avg

11.7%

📊

Deep Analysis

Revenue growth year-over-year (YoY) compares the company’s current quarterly revenue to the same quarter one year earlier.

Eli Lilly’s 55.5% growth rate is far above the sector median of 7.9%, placing it in the 98th percentile among sector peers — meaning it outperforms 98% of comparable companies. However, no trend data is available: the year-over-year change and quarter-over-quarter change are both marked as N/A, and only a single historical value of 55.5% is provided. With an exceptionally high level but no trend information, the uncertainty about whether this rapid growth can be sustained introduces risk; a single data point cannot confirm a lasting trajectory. This metric alone might suggest a bullish case, but the overall NEUTRAL verdict reflects that the lack of trend data tempers conviction. The 55.5% figure does not contradict the neutral stance — it highlights an outstanding current result while acknowledging insufficient evidence to upgrade the rating.

Frequently Asked Questions

What does the Revenue Growth (YoY) tell investors about LLY?

Year-over-year revenue acceleration is one of the strongest signals of business momentum. Sustained >15% growth is rare and typically re-rated by the market.

How is the Revenue Growth (YoY) calculated?

Revenue Growth (YoY) is calculated as: (Revenue_t - Revenue_t-4) / Revenue_t-4.

Who are LLY's closest peers by Revenue Growth (YoY)?

The closest peers by Revenue Growth (YoY) include: COP (-4.6%), CCI (-4.8%), EMN (-4.9%), IPG (-5.1%), LEN (-5.2%).

The Formula

(Revenue_t - Revenue_t-4) / Revenue_t-4

Why It Matters

Year-over-year revenue acceleration is one of the strongest signals of business momentum. Sustained >15% growth is rare and typically re-rated by the market.